DOI: 10.36347/sjmcr.2013.v01i01.004

Pages: 8-11

Abstract: Hemolytic anemia drugs induced are rare and, clinical laboratories are often required to provide the optimal serological tests to confirm the diagnosis. Some of the mechanisms involved in hemolytic anemia drugs are controversial. Unfortunately, most of the drugs that cause acute, severe intravascular hemolysis and sometimes renal failure, disseminated intravascular coagulation and death, seem to work by different mechanisms, and usually involve drug-dependent antibodies that activate the complement with pancytopenia or agranulocytosis in peripheral blood. This study confirms a case study of hemolytic anemia drugs induced by antihypertensive agents.